Listen to researchers in Spermatech and investor Gunnar Hvammen talk about male contraceptives on the Norwegian Broadcasting Corporation NRK2
Read the article from This Magazine about why a male contraceptive pill is still not on the market
Spermatech is financed by The Research Council of Norway. Read about Spermatech and our research in the latest issue of their news journal FUGE Nytt (norwegian).
This film from the School of Biotechnology is presented to students of secondary schools in Norway. The main goal is to encourage young people to study natural sciences. Spermatech is used as an example of a small biotechnology company situated in Norway (norwegian).
Bioworld International is a recognized newspaper which gives weekly reports about global technology developments. Spermatech's collaboration with the early drug discovery company Evotec AG attracted international attention and the story was covered in this issue of Bioworld International.
Read about Spermatech and our technology in the journal of the Norwegian Biochemical Society.